2013
DOI: 10.1001/jamaneurol.2013.592
|View full text |Cite
|
Sign up to set email alerts
|

Insights From LGI1 and CASPR2 Potassium Channel Complex Autoantibody Subtyping

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
174
2
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 174 publications
(188 citation statements)
references
References 17 publications
11
174
2
1
Order By: Relevance
“…Patients were identified by the following 2 mechanisms: 1) A search of the Mayo Clinic Life Sciences System (a clinical data repository containing patient demographics, diagnoses, hospital and clinical notes, laboratory results, and pathology data obtained from multiple clinical and hospital source systems) by using the keywords "voltagegated potassium channel" or "VGKC" and "seizures," "epilepsy," "encephalitis" or "encephalopathy" identified 11 patients presenting between January 1, 2001, and June 1, 2008, seropositive for VGKC Ab with associated seizures; 2) From June 1, 2008, to June 30, 2010, comprehensive serologic evaluation of patients with unexplained neurologic symptoms was performed at our institution, identifying 1992 patients who were seropositive for VGKC Ab. 13 A search of this data base identified 33 additional patients with associated seizures.…”
Section: Methodsmentioning
confidence: 99%
“…Patients were identified by the following 2 mechanisms: 1) A search of the Mayo Clinic Life Sciences System (a clinical data repository containing patient demographics, diagnoses, hospital and clinical notes, laboratory results, and pathology data obtained from multiple clinical and hospital source systems) by using the keywords "voltagegated potassium channel" or "VGKC" and "seizures," "epilepsy," "encephalitis" or "encephalopathy" identified 11 patients presenting between January 1, 2001, and June 1, 2008, seropositive for VGKC Ab with associated seizures; 2) From June 1, 2008, to June 30, 2010, comprehensive serologic evaluation of patients with unexplained neurologic symptoms was performed at our institution, identifying 1992 patients who were seropositive for VGKC Ab. 13 A search of this data base identified 33 additional patients with associated seizures.…”
Section: Methodsmentioning
confidence: 99%
“…Epidemiology: In the UK, where the incidence of encephalitis is estimated at 5.23 cases/100,000/year based upon admissions to the National Health Service between 2005 and 2009, Granerod and colleagues [120] estimated the incidence of encephalitis as 4.32 cases/100,000 population/year. A capture-recapture model estimated the incidence of encephalitis to be 8.66 cases/100,000/year.…”
Section: Anti-vgkc-complex Encephalitismentioning
confidence: 99%
“…Only about 4% to 5.5% of unselected cases were seropositive by RIA with confirmatory retesting using 125 I-α-dendrotoxin alone (radioligand for Kv1.1, Kv1.2, and Kv1.6 channels) [3] [18] [19], making the test unreliable as a screen for LE without further subtyping for LGI1 and CASPR2-IgG. So selected, 26% [3] to 28% [19] of seropositive VGKC sera revealed reactivity with LGI1 and/or CASPR2-IgG, with a significant association between LGI1-IgG-positivity and cognitive impairment andseizures (P < 0.05), and CASPR2-IgG-positivity and peripheral motor excitability (P = 0.004) [3], however neither autoantibody was pathognomonic for a specific neurologic presentation. Yet there was concern for screening of unselected sera for VGKC-complex antibodies by RIA.…”
Section: Vgkc-complex Subtypingmentioning
confidence: 99%
“…There is a diversity and overlap of neurological phenotypes that relate to VGKC-Complex-IgG values in the serum and CSF and Ig-subtype specificity. The commonest presentation of VGKCcomplex autoantibodies is LE in the CNS and neuromyotonia or Morvan syndrome in the PNS [3]. We present the clinical and laboratory findings of a patient that manifested PNS, CNS and autonomic nervous system (ANS) involvement.…”
Section: Introductionmentioning
confidence: 98%